Clinical Trial Update: Allopregnanolone as a Regenerative Treatment for Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating allopregnanolone as a regenerative treatment for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Roberta Brinton | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED